These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8288409)

  • 1. Difference in plasminogen activator inhibitor activity between non-Q-wave infarction and Q-wave infarction.
    Ogawa H; Misumi I; Sakamoto T; Masuda T; Okubo H; Miyao Y; Yasue H
    Int J Cardiol; 1993 Oct; 41(3):201-8. PubMed ID: 8288409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction.
    Sakamoto T; Yasue H; Ogawa H; Misumi I; Masuda T
    Am J Cardiol; 1992 Aug; 70(3):271-6. PubMed ID: 1632387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
    Goodman SG; Langer A; Ross AM; Wildermann NM; Barbagelata A; Sgarbossa EB; Wagner GS; Granger CB; Califf RM; Topol EJ; Simoons ML; Armstrong PW
    Circulation; 1998 Feb; 97(5):444-50. PubMed ID: 9490238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.
    Hirashima O; Ogawa H; Oshima S; Sakamoto T; Honda Y; Sakata S; Masuda T; Miyao Y; Yasue H
    Am Heart J; 1995 Nov; 130(5):933-9. PubMed ID: 7484753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.
    Barbash GI; Hod H; Roth A; Miller HI; Rath S; Zahav YH; Modan M; Zivelin A; Laniado S; Seligsohn U
    Am J Cardiol; 1989 Dec; 64(19):1231-5. PubMed ID: 2511742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma plasminogen activator inhibitor activity after coronary spasm.
    Misumi I; Ogawa H; Masuda T; Sakamoto T; Okumura K; Yasue H
    Int J Cardiol; 1993 Aug; 41(1):21-9. PubMed ID: 8225669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase.
    Morris JA; Muller DW; Topol EJ
    Am Heart J; 1991 Aug; 122(2):375-80. PubMed ID: 1907086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Q-wave regression unrelated to patency of infarct-related artery or left ventricular ejection fraction or volume after anterior wall acute myocardial infarction treated with or without reperfusion therapy.
    Iwasaki K; Kusachi S; Hina K; Yamasaki S; Kita T; Endo C; Tsuji T
    Am J Cardiol; 1995 Jul; 76(1):14-20. PubMed ID: 7793396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction.
    Moliterno DJ; Lange RA; Meidell RS; Willard JE; Leffert CC; Gerard RD; Boerwinkle E; Hobbs HH; Hillis LD
    Circulation; 1993 Sep; 88(3):935-40. PubMed ID: 8353920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
    Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
    Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects on high resolution electrocardiogram of coronary angioplasty in acute myocardial infarct].
    Bruna C; Vado A; Rossetti G; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Uslenghi E
    G Ital Cardiol; 1997 Nov; 27(11):1144-52. PubMed ID: 9463058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.
    Barbagelata A; Califf RM; Sgarbossa EB; Goodman SG; Stebbins AL; Granger CB; Suarez LD; Borruel M; Gates K; Starr S; Wagner GS
    J Am Coll Cardiol; 1997 Mar; 29(4):770-7. PubMed ID: 9091523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction.
    Bode C; Schoenermark S; Schuler G; Zimmermann R; Schwarz F; Kuebler W
    Am J Cardiol; 1988 May; 61(13):971-4. PubMed ID: 2452564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators).
    Langer A; Goodman SG; Topol EJ; Charlesworth A; Skene AM; Wilcox RG; Armstrong PW
    J Am Coll Cardiol; 1996 May; 27(6):1327-32. PubMed ID: 8626939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early T wave inversion after thrombolytic therapy predicts better coronary perfusion: clinical and angiographic study.
    Matetzky S; Barabash GI; Shahar A; Rabinowitz B; Rath S; Zahav YH; Agranat O; Kaplinsky E; Hod H
    J Am Coll Cardiol; 1994 Aug; 24(2):378-83. PubMed ID: 8034871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction.
    Sane DC; Stump DC; Topol EJ; Sigmon KN; Kereiakes DJ; George BS; Mantell SJ; Macy E; Collen D; Califf RM
    Thromb Haemost; 1991 Mar; 65(3):275-9. PubMed ID: 1904653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.